Therapeutic inorganic ions in bioactive glasses to enhance bone formation and beyond
- 19 November 2012
- journal article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 1 (3), 254-256
- https://doi.org/10.1039/c2bm00116k
Abstract
Bioactive glasses (BG) are being widely used for bone tissue engineering applications due to their bioactivity (ability to form strong bonds to bone) and their stimulating effects on bone formation. Recently, progress has been made to enhance the biological impact of BGs by incorporating specific metallic ions in silicate (or phosphate) glasses, including boron, copper, cobalt, silver, zinc and strontium. This review summarizes the newest developments on novel compositions of bioactive glasses in the field of bone tissue engineering related to osteogenesis and angiogenesis. Furthermore, new applications areas for bioactive glasses, including nerve regeneration and cancer treatment, are highlighted.This publication has 35 references indexed in Scilit:
- In-vitro Degradation and Bioactivity of Tailored Amorphous Multi Porous Scaffold StructureJournal of the American Ceramic Society, 2012
- Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developmentsJournal of The Royal Society Interface, 2011
- Time-dependent evaluation of mechanical properties and in vitro cytocompatibility of experimental composite-based nerve guidance conduitsJournal of the Mechanical Behavior of Biomedical Materials, 2011
- Bioinorganics and biomaterials: Bone repairActa Biomaterialia, 2011
- Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffoldsBiomaterials, 2011
- Bioactive glass in tissue engineeringActa Biomaterialia, 2011
- Effect of cerium ion on the proliferation, differentiation and mineralization function of primary mouse osteoblasts in vitroJournal of Rare Earths, 2010
- Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffoldsJournal of The Royal Society Interface, 2009
- Cerium and yttrium oxide nanoparticles are neuroprotectiveBiochemical and Biophysical Research Communications, 2006
- A Question of DoseScience, 2003